Gene · 6595
Papers3,459
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,459
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| A general calculus of fitness landscapes finds genes under selection in cancers. | Genome Res | 2022 | 35301263 | PubTator, text mining | PubMed |
| Multi-omic alterations of the SWI/SNF complex define a clinical subgroup in lung adenocarcinoma. | Clin Epigenetics | 2022 | 35300733 | PubTator, text mining | PubMed |
| Comorbidities rather than older age define outcome in adult patients with tumors of the Ewing sarcoma family. | Cancer Med | 2022 | 35297222 | PubTator, text mining | PubMed |
| SMARCA2 deficiency in NSCLC: a clinicopathologic and immunohistochemical analysis of a large series from a single institution. | Environ Health Prev Med | 2022 | 35289322 | PubTator, text mining | PubMed |
| Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors. | Oncologist | 2022 | 35278076 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children. | Int J Mol Sci | 2022 | 35269896 | PubTator, text mining | PubMed |
| Tracking the Molecular Fingerprint of Head and Neck Cancer for Recurrence Detection in Liquid Biopsies. | Int J Mol Sci | 2022 | 35269544 | PubTator, text mining | PubMed |
| Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges. | J Clin Med | 2022 | 35268551 | PubTator, text mining | PubMed |
| Missense Variants Reveal Functional Insights Into the Human ARID Family of Gene Regulators. | J Mol Biol | 2022 | 35257783 | PubTator, text mining | PubMed |
| SMARCB1 (INI1)-Deficient Sinonasal Carcinoma with Yolk Sac differentiation Showing Co-loss of SMARCA4 Immunostaining - A Case Report and Literature Review. | Head Neck Pathol | 2022 | 35257325 | PubTator, text mining | PubMed |
| Methylation- and homologous recombination deficiency-related mutant genes predict the prognosis of lung adenocarcinoma. | J Clin Lab Anal | 2022 | 35238419 | PubTator, text mining | PubMed |
| OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR. | Commun Biol | 2022 | 35233061 | PubTator, text mining | PubMed |
| Systematic review and meta-analysis of genomic alterations in acral melanoma. | Pigment Cell Melanoma Res | 2022 | 35229492 | PubTator, text mining | PubMed |
| Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine. | Front Bioeng Biotechnol | 2022 | 35223797 | PubTator, text mining | PubMed |
| Thoracic SMARCA2-deficient But SMARCA4-preserved Tumors With Undifferentiated Morphology Combined With Claudin-4 Negativity. | Am J Surg Pathol | 2022 | 35220352 | PubTator, text mining | PubMed |
| Differential requirements for different subfamilies of the mammalian SWI/SNF chromatin remodeling enzymes in myoblast cell cycle progression and expression of the Pax7 regulator. | Biochim Biophys Acta Gene Regul Mech | 2022 | 35217218 | PubTator, text mining | PubMed |
| A Contemporary Review of Molecular Therapeutic Targets for Adenoid Cystic Carcinoma. | Cancers (Basel) | 2022 | 35205740 | PubTator, text mining | PubMed |
| Development of Gene Expression-Based Random Forest Model for Predicting Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 | 35205629 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6595/papers?page=42